XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Non-Controlling Interest
Total
Balance at beginning of year at Dec. 31, 2022 $ 750 $ 342,664 $ (328,042) $ (6,103) $ 2,460 $ 11,729
Balance at beginning of year (in shares) at Dec. 31, 2022 75,020          
Net income (loss)     (31,152)   15 (31,137)
Issuance of common shares related to acquisitions $ 2 444       446
Issuance of common shares related to acquisitions (in shares) 40          
Issuance of common shares related to Public Warrant exercise $ 2 3,142       3,144
Issuance of common shares related to Public Warrant exercise (in shares) 229          
Issuance of common shares related to stock options exercised $ 1 62       63
Issuance of common shares related to stock options exercised (in shares) 6          
Issuance of common shares related to conversion of Series A Convertible Preferred Shares $ 1 253       254
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares) 22          
Issuance of common shares related to purchase of non-controlling interest $ 1 474     (2,475) (2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares) 100          
Accretion of Series A Convertible Preferred Shares   (341)       (341)
Other comprehensive income (loss)       1,564   1,564
Equity-based compensation $ 3 3,854       3,857
Equity-based compensation (in shares) 311          
Net share settlement of equity awards   (1,841)       (1,841)
Balance at end of year at Jun. 30, 2023 $ 760 348,711 (359,194) (4,539)   (14,262)
Balance at end of year (in shares) at Jun. 30, 2023 75,728          
Balance at beginning of year at Mar. 31, 2023 $ 759 345,840 (332,383) (3,881) 2,475 12,810
Balance at beginning of year (in shares) at Mar. 31, 2023 75,628          
Net income (loss)     (26,811)     (26,811)
Issuance of common shares related to purchase of non-controlling interest $ 1 474     $ (2,475) (2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares) 100          
Accretion of Series A Convertible Preferred Shares   87       87
Other comprehensive income (loss)       (658)   (658)
Equity-based compensation   2,310       2,310
Balance at end of year at Jun. 30, 2023 $ 760 348,711 (359,194) (4,539)   (14,262)
Balance at end of year (in shares) at Jun. 30, 2023 75,728          
Balance at beginning of year at Dec. 31, 2023 $ 880 471,666 (362,624) 3,818   113,740
Balance at beginning of year (in shares) at Dec. 31, 2023 88,051          
Net income (loss)     (41,432)     (41,432)
Issuance of common shares related to "at-the-market" offering program, net of issuance costs $ 1 624       625
Issuance of common shares related to "at-the-market" offering program, net of issuance costs (in shares) 60          
Issuance of common shares related to stock options exercised   12       12
Issuance of common shares related to stock options exercised (in shares) 1          
Issuance of common shares related to conversion of Series A Convertible Preferred Shares   174       174
Other comprehensive income (loss)       4,087   4,087
Equity-based compensation $ 3 5,478       5,481
Equity-based compensation (in shares) 254          
Net share settlement of equity awards   (1,159)       (1,159)
Balance at end of year at Jun. 30, 2024 $ 884 476,795 (404,056) 7,905   81,528
Balance at end of year (in shares) at Jun. 30, 2024 88,366          
Balance at beginning of year at Mar. 31, 2024 $ 883 473,064 (386,297) 4,034   91,684
Balance at beginning of year (in shares) at Mar. 31, 2024 88,282          
Net income (loss)     (17,759)     (17,759)
Issuance of common shares related to "at-the-market" offering program, net of issuance costs $ 1 624       625
Issuance of common shares related to "at-the-market" offering program, net of issuance costs (in shares) 60          
Issuance of common shares related to stock options exercised   12       12
Issuance of common shares related to stock options exercised (in shares) 1          
Accretion of Series A Convertible Preferred Shares   87       87
Other comprehensive income (loss)       3,871   3,871
Equity-based compensation   3,025       3,025
Equity-based compensation (in shares) 23          
Net share settlement of equity awards   (17)       (17)
Balance at end of year at Jun. 30, 2024 $ 884 $ 476,795 $ (404,056) $ 7,905   $ 81,528
Balance at end of year (in shares) at Jun. 30, 2024 88,366